Search Results
Feb 04, 2026, 22:00 ET Halper Sadeh LLC Encourages STEL, GORO, SKYT, VTYX Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-stel-goro-skyt-vtyx-shareholders-to-contact-the-firm-to-discuss-their-rights-302679624.htmlSOURCE
More news about: Halper Sadeh LLP
Feb 04, 2026, 13:16 ET SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--SKYT, GORO, STEL, and VTYX
VTYX) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Ventyx shareholders are expected to receive $14.00
More news about: Monteverde & Associates PC
Jan 26, 2026, 13:33 ET Halper Sadeh LLC Encourages NATH, VTYX, SKYT Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-nath-vtyx-skyt-shareholders-to-contact-the-firm-to-discuss-their-rights-302670156.htmlSOURCE
More news about: Halper Sadeh LLP
Jan 23, 2026, 20:31 ET Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYX
Ventyx Biosciences, Inc. (NasdaqGS: VTYX) to Eli Lilly and Company (NYSE: LLY). Under the terms of the proposed transaction, shareholders of Ventyx will receive $14.00 in cash for each share
More news about: Kahn Swick & Foti, LLC
Jan 23, 2026, 13:40 ET SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VTYX, ALEX, RVYL, and FFWM
VTYX) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Ventyx shareholders are expected to receive $14.00
More news about: Monteverde & Associates PC
Jan 21, 2026, 00:37 ET Halper Sadeh LLC Encourages SEE, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-see-vtyx-sncy-shareholders-to-contact-the-firm-to-discuss-their-rights-302666127.htmlSOURCE
More news about: Halper Sadeh LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jan 14, 2026, 14:35 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--FFIC, OCFC, VTYX, and ONTF
VTYX) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Ventyx shareholders are expected to receive $14.00
More news about: Monteverde & Associates PC
Jan 13, 2026, 01:44 ET Halper Sadeh LLC Encourages VTYX, SNCY, EKSO Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-vtyx-sncy-ekso-shareholders-to-contact-the-firm-to-discuss-their-rights-302659156.htmlSOURCE
More news about: Halper Sadeh LLP
Jan 12, 2026, 15:00 ET Halper Sadeh LLC Encourages VTYX, FONR, SNCY, FFIC Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-vtyx-fonr-sncy-ffic-shareholders-to-contact-the-firm-to-discuss-their-rights-302658753.htmlSOURCE
More news about: Halper Sadeh LLP
Jan 08, 2026, 20:57 ET Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYX
Ventyx Biosciences, Inc. (NasdaqGS: VTYX) to Eli Lilly and Company (NYSE: LLY). Under the terms of the proposed transaction, shareholders of Ventyx will receive $14.00 in cash for each share
More news about: Kahn Swick & Foti, LLC
Jan 08, 2026, 20:30 ET INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Ventyx Biosciences, Inc. (NASDAQ: VTYX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Ventyx Biosciences, Inc. ("Ventyx") (NASDAQ: VTYX), resulting from allegations of providing potentially misleading business information to the investing public.
More news about: Edelson Lechtzin LLP
Jan 08, 2026, 11:51 ET Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-holx-vtyx-qrvo-tex-shareholders-to-contact-the-firm-to-discuss-their-rights-302656547.htmlSOURCE
More news about: Halper Sadeh LLP
Jan 08, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jan 07, 2026, 19:51 ET Shareholder Alert: The Ademi Firm investigates whether Ventyx Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE, Jan. 7, 2026 /PRNewswire/ -- Ademi LLP is investigating Ventyx (NASDAQ: VTYX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Eli Lilly.
More news about: Ademi LLP
Jan 07, 2026, 16:17 ET Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
INDIANAPOLIS, Jan. 7, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Ventyx Biosciences, Inc. (Nasdaq: VTYX), a San Diego-based clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammatory-mediated
More news about: Eli Lilly and Company
Jan 01, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Dec 11, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP